Allogeneic γδ T Cell Therapy for Treatment of Patients With Advanced Solid Cancers
Condition(s):Advanced Solid TumourLast Updated:February 22, 2021Recruiting
Hide Studies Not Open or Pending
Condition(s):Advanced Solid TumourLast Updated:February 22, 2021Recruiting
Condition(s):Stage III Adult Soft Tissue SarcomaLast Updated:February 22, 2021Recruiting
Condition(s):Colonic DiseaseLast Updated:February 22, 2021Enrolling by invitation
Condition(s):Esophageal Squamous Cell CarcinomaLast Updated:February 22, 2021Recruiting
Condition(s):Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Myelodysplastic SyndromesLast Updated:February 22, 2021Recruiting
Condition(s):Aortic Arch; Aneurysm, DissectingLast Updated:February 22, 2021Recruiting
Condition(s):Esophagus Cancer; Esophageal Squamous Cell Carcinoma; Chemoradiotherapy; Radiation Therapy; PostoperativeLast Updated:February 22, 2021Recruiting
Condition(s):NSCLC Stage IV; EGFR T790MLast Updated:February 22, 2021Recruiting
Condition(s):Nasopharyngeal CarcinomaLast Updated:February 22, 2021Recruiting
Condition(s):HER2-negative Breast Cancer; Gastric Adenocarcinoma; Cholangiocarcinoma; Pancreatic CancerLast Updated:February 22, 2021Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.